Literature DB >> 1463354

Effects of long-term in vitro cultivation on the virulence of cloned lines of Leishmania major promastigotes.

M Segovia1, J M Artero, E Mellado, M L Chance.   

Abstract

The virulences of several clones from a single Leishmania major strain were studied in BALB/c mice. Clones showed the same pattern of infectivity and virulence two months after cloning as the parental population. After prolonged in vitro culture, however, it was apparent that two types of virulent clones existed: although the level of virulence remained stable in some clones, in others, such as C-11, it progressively decreased, as in the parental population. The progressive loss in virulence in a continuously cultured mixed population was probably due to selection, as the initial mixture of a stable virulent clone and a stable avirulent clone eventually yielded a totally avirulent promastigote population. After cultivation for 12 months, neither clone C-11 nor the parental population produced lesions in inoculated mice but virulent parasites were recovered from the inguinal nodes of the mice, possibly as a result of selection in vivo for virulent parasites.

Entities:  

Mesh:

Year:  1992        PMID: 1463354     DOI: 10.1080/00034983.1992.11812677

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  13 in total

1.  Leishmania major Hsp100 is required chiefly in the mammalian stage of the parasite.

Authors:  A Hübel; S Krobitsch; A Hörauf; J Clos
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Spontaneous excision and facilitated recovery as a control for phenotypes arising from RNA interference and other dominant transgenes.

Authors:  Erin A Brettmann; Lon-Fye Lye; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2018-02-03       Impact factor: 1.759

3.  Acanthamoeba castellanii : growth on human cell layers reactivates attenuated properties after prolonged axenic culture.

Authors:  Martina Koehsler; David Leitsch; Michael Duchêne; Markus Nagl; Julia Walochnik
Journal:  FEMS Microbiol Lett       Date:  2009-06-05       Impact factor: 2.742

4.  Virulence attenuation of a UDP-galactose/N-acetylglucosamine beta1,4 galactosyltransferase expressing Leishmania donovani promastigote.

Authors:  S K Bhaumik; M Singh; R Basu; S Bhaumik; K Roychoudhury; K Naskar; S Roy; T De
Journal:  Glycoconj J       Date:  2008-01-16       Impact factor: 2.916

5.  In vitro Screening of Antileishmanial Activity of Natural Product Compounds: Determination of IC50, CC50 and SI Values.

Authors:  Olga S Koutsoni; Kalliopi Karampetsou; Eleni Dotsika
Journal:  Bio Protoc       Date:  2019-11-05

6.  Impact of continuous axenic cultivation in Leishmania infantum virulence.

Authors:  Diana Moreira; Nuno Santarém; Inês Loureiro; Joana Tavares; Ana Marta Silva; Ana Marina Amorim; Ali Ouaissi; Anabela Cordeiro-da-Silva; Ricardo Silvestre
Journal:  PLoS Negl Trop Dis       Date:  2012-01-24

7.  Pathogenicity of Leishmania donovani is associated with the high expression of a group low molecular weight proteins.

Authors:  Partha Mitra
Journal:  Trop Parasitol       Date:  2015 Jul-Dec

8.  Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.

Authors:  Marcelo P Oliveira; Vívian T Martins; Thaís T O Santos; Daniela P Lage; Fernanda F Ramos; Beatriz C S Salles; Lourena E Costa; Daniel S Dias; Patrícia A F Ribeiro; Mônica S Schneider; Ricardo A Machado-de-Ávila; Antônio L Teixeira; Eduardo A F Coelho; Miguel A Chávez-Fumagalli
Journal:  Int J Mol Sci       Date:  2018-01-03       Impact factor: 5.923

Review 9.  Live vaccination tactics: possible approaches for controlling visceral leishmaniasis.

Authors:  Noushin Saljoughian; Tahareh Taheri; Sima Rafati
Journal:  Front Immunol       Date:  2014-03-31       Impact factor: 7.561

10.  Identification of differentially expressed proteins from Leishmania amazonensis associated with the loss of virulence of the parasites.

Authors:  Rubens D M Magalhães; Mariana C Duarte; Eliciane C Mattos; Vivian T Martins; Paula S Lage; Miguel A Chávez-Fumagalli; Daniela P Lage; Daniel Menezes-Souza; Wiliam C B Régis; Maria J Manso Alves; Manuel Soto; Carlos A P Tavares; Ronaldo A P Nagen; Eduardo A F Coelho
Journal:  PLoS Negl Trop Dis       Date:  2014-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.